Ergocalciferol 8000 IU By Virtus Pharmaceuticals Overview & Drug Interactions

Check For Interactions With Ergocalciferol 8000 IU

Supplement: Ergocalciferol 8000 IU by Virtus Pharmaceuticals

Ergocalciferol 8000 IU Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Ergocalciferol 8000 IU by Virtus Pharmaceuticals

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
400 IU
Maximum serving Sizes:
400 IU
Servings per container 1200
UPC/BARCODE 369543234601

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin D
400 IU
Vitamin D 100%

Other Ingredients:
Propylene Glycol


Label Statments:


Formulation
- Oral Solution, USP
- Made in USA
FDA Statement of Identity
- Vitamin D Supplement Drops
General Statements
- The US RDA for vitamin D is 400 IU for children and adults.
Formula
- 8000 IU (0.2 mg) Ergocalciferol per ml Description: Each ml contains 8000 IU (0.2 mg) of ergocalciferol (vitamin D2) dissolved in propylene glycol.
- How Supplied: Each 60 ml polycarbonate screw top bottle contains 60 ml ergocalciferol in a propylene glycol base (0.2 mg ergocalciferol per ml).
- Adequate intake (AI) (minimum daily intake) of vitamin D is needed to support calcium metabolism and bone health, particularly in the young and old.
Suggested/Recommended/Usage/Directions
- Directions for Use: 400 IU daily to be taken orally using the supplied pre-measured syringe. Submerge the tip of the syringe into the liquid, pull plunger back to bring the liquid to the 400 IU mark, and dispense into mouth. Do not fill syringe entirely.
Precautions
- Do not fill syringe entirely. Contraindications: Contraindicated in people with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D. Warning: In case of accidental overdose contact a doctor or poison control center immediately.
- Hypersensitivity to vitamin D may be a causative factor in infants with idiopathic hypercalcemia. In these children, vitamin D must be strictly restricted.
- Caution: Adequate dietary calcium is necessary for response to vitamin D therapy. Side Effects: Metabolic side effects include hypercalcemia.
- You may report serious side effects by calling Virtus at 1-888-848-3593 or FDA at 1-800-FDA-1088
- Keep this and all medications out of the reach of children.
- Tamper Resistant Feature: Do not use if imprinted seal on cap is broken or missing.
Storage
- Store at 20 degrees-25 degrees C (68 degrees-77 degrees F); excursions permitted between 15 degrees-30 degrees C (59 degrees-86 degrees F).
FDA Disclaimer Statement
- This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Brand Information

See all products by this brand

Manufactured for
Name Virtus Pharmaceuticals, LLC
City Tampa
State FL
ZipCode 33619
Phone Number 1-888-848-3593

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.